Sector: Health Care
Director information for CERTARA INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Arjun Bedi | Senior Strategic Advisor | 63 | ["More than 35 years of leadership experience advising senior executives and boards on strategy, growth, and large-scale transformation", "Deep expertise in the healthcare and life sciences industries", "Extensive experience in strategic leadership, operational execution, and digital transformation", "Experience in leading technology-enabled transformations for global health and life sciences companies", "Founder of the Health & Life Sciences CEO Forum", "B.A. (Honors) in Economics from the University of Delhi", "M.B.A. in Management Information Systems from Temple University"] | ["Audit"] | 2026 |
| David Spaight | Director | 67 | ["Operating Partner at Arsenal Capital Partners since 2016", "Board member of CellCarta", "Executive chair roles at multiple healthcare and life sciences companies", "Chairman and CEO of WIL Research from 2010 to 2016", "President of MDS Pharma Services", "Senior executive roles at Fisher Scientific and PerkinElmer", "Chairman of the Association of Clinical Research Organizations (ACRO)"] | ["Compensation"] | 2026 |
| Eran Broshy | 67 | ["More than 30 years of leadership experience in the healthcare industry", "Experience as CEO of Syneos Health until 2008 and Chair of the Board until 2010", "15 years at The Boston Consulting Group as a partner leading the healthcare practice", "Served on multiple healthcare company boards", "Experience with private equity firms supporting healthcare investment strategies", "Holds a B.S. from MIT, an M.S. from Stanford, and an M.B.A. from Harvard"] | ["Audit", "NCGC (Chair)"] | 2026 | |
| James Cashman III | Chairman of the Board | 72 | ["Extensive executive leadership experience in the technology and software industries", "Expertise in financial management, strategic growth, and sales execution", "Experience leading a global public company and serving as both Chief Executive Officer and Chair of the Board", "Insight into technology-driven business strategy, operational scale, and corporate governance"] | ["Compensation", "NCGC"] | 2026 |
| John Reynders, PhD | Director | 61 | ["Chief Data Scientist and Venture Partner at Iaso Ventures", "Founder and CEO of Latent Strategies, LLC", "Chief Data Sciences Officer of Neumora Therapeutics", "Vice President of Data Sciences, Genomics, and Bioinformatics at Alexion Pharmaceuticals", "Founding Chief Information Officer of Moderna Therapeutics", "Vice President of R&D Information at AstraZeneca", "Senior leadership positions at Johnson & Johnson", "Chief Information Officer at Lilly Research Laboratories", "Vice President of Informatics at Celera Genomics", "Scientific leadership roles at Los Alamos National Laboratory", "B.S. in Mathematics from Rensselaer Polytechnic Institute", "Ph.D. in Applied and Computational Mathematics from Princeton University", "M.B.A. from the Kellogg School of Management at Northwestern University"] | ["Audit"] | 2026 |
| Jon Resnick | Chief Executive Officer | 53 | ["More than 20 years of leadership experience in the life sciences, healthcare analytics, and professional services industries", "Chief Executive Officer of Certara, Inc. since January 1, 2026", "Former President of the United States and Canada regional business of IQVIA Holdings Inc.", "Held various senior leadership roles within IMS Health", "Worked for the United States Senate Committee on Finance advising on healthcare policy"] | [] | 2026 |
| Matthew Walsh | Executive Vice President and Chief Financial Officer | 59 | ["Executive Vice President and Chief Financial Officer of Organon & Co.", "Former Executive Vice President and Chief Financial Officer of Allergan plc", "Chief Financial Officer of Catalent, Inc.", "President, Chief Financial Officer, and Acting Chief Executive Officer of Escala Group, Inc.", "Experience in global finance, capital markets, operations, and strategic transactions"] | ["Audit (Chair)"] | 2026 |
| Nancy Killefer | Director | 72 | ["More than 20 years of experience in management consulting, government leadership, and organizational transformation", "Senior Partner at McKinsey & Company", "Director of the Washington, D.C. office and Managing Partner of the Public Sector Practice at McKinsey & Company", "Assistant Secretary for Management, Chief Financial Officer, and Chief Operating Officer of the United States Department of the Treasury", "B.A. in Economics from Vassar College", "M.S. in Management from the Massachusetts Institute of Technology"] | ["Compensation (Chair)", "NCGC"] | 2026 |
| Stephen McLean | Director | 68 | ["Partner at Arsenal Capital Partners since 2010", "Serves on boards of several private companies", "Experience in healthcare investing, company formation, and strategic growth", "Background in private equity, financial oversight, and board leadership"] | ["NCGC"] | 2026 |
